Trevi Therapeutics Inc.

NASDAQ: TRVI · Real-Time Price · USD
7.51
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.52
0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

Trevi Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
117.06M 19.37M 34.1M 16.05M 12.96M 13.81M 32.4M 25.96M 13.75M 11.65M 12.59M 66.57M 24.7M 29.11M 36.83M 29.32M 36.42M 41.57M
Short-Term Investments
86.83M 83.88M 73.53M 49.44M 56.53M 59.01M 50.57M 62.9M 80.4M 99.61M 107.92M 59.03M 53.16M n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1M n/a n/a n/a n/a n/a
Other Long-Term Assets
68K 241K 243K 256K 273K 311K 297K 297K 68K 225K 205K 922K 413K 398K 334K 667K 410K 410K
Receivables
n/a n/a 532K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
3.34M 834K 335K 667K 830K 721K 955K 1.05M 2.08M 1.61M 1.31M 421K 382K 249K n/a n/a n/a 245K
Total Current Assets
207.23M 105.62M 109.43M 67.34M 72.13M 76.77M 87.55M 93.95M 99.21M 114.2M 122.62M 127.32M 79.89M 29.84M 37.96M 30.71M 38.48M 42.16M
Property-Plant & Equipment
1.04M 1.14M 1.23M 1.32M 1.41M 1.48M 1.56M 1.65M 1.7M 1.78M 194K 121K 116K 149K 184K 222K 259K 295K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
1.11M 1.38M 1.47M 1.57M 1.68M 1.79M 1.86M 1.94M 1.76M 2M 399K 1.04M 1.53M 547K 518K 889K 669K 705K
Total Assets
208.34M 107M 110.9M 68.91M 73.81M 78.56M 89.4M 95.9M 100.98M 116.2M 123.02M 128.36M 81.41M 30.39M 38.48M 31.6M 39.15M 42.86M
Account Payables
2.97M 1.42M 3.41M 1.61M 1.51M 2.11M 1.81M 1.26M 1.35M 1.98M 2.86M 2.33M 3.94M 1.74M 2.85M 2.23M 3.49M 801K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.81M 3.31M 3.32M n/a
Short-Term Debt
286K n/a n/a n/a n/a 322K 306K 292K 277K 7.48M 7M 7M 7M 7M 5.83M 4.25M 2.5M 690K
Other Current Liabilities
4.11M 1.07M 2.54M n/a 3.43M -322K 1.79M 2.11M 1.72M n/a n/a n/a n/a 125K 2.67M 2.35M n/a 3.27M
Total Current Liabilities
9.24M 6.87M 10.51M 9.12M 6.75M 5.28M 5.82M 5.17M 4.71M 13.2M 13.4M 14.64M 15.43M 12.87M 12.72M 9.91M 9.41M 5.34M
Long-Term Debt
605K n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.15M 3.8M 5.43M 7.06M 8.65M 10.24M 11.91M 13.52M
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3K 15K 35K n/a n/a n/a n/a 202K
Total Long-Term Liabilities
605K 681K 747K 816K 884K 949K 1.03M 1.11M 1.19M 1.27M 2.16M 3.82M 5.47M 7.06M 8.68M 10.3M 12M 13.84M
Total Liabilities
9.85M 7.55M 11.26M 9.94M 7.64M 6.22M 6.86M 6.29M 5.9M 14.47M 15.56M 18.46M 20.9M 19.92M 21.4M 20.22M 21.41M 19.18M
Total Debt
891K 957K 1.03M 1.11M 1.19M 1.27M 1.34M 1.41M 1.47M 9.02M 9.18M 10.86M 12.52M 14.18M 14.63M 14.5M 14.45M 14.33M
Common Stock
122K 100K 94K 75K 73K 69K 68K 64K 63K 60K 60K 58K 40K 31K 29K 22K 21K 20K
Retained Earnings
-309.69M -297.38M -287.05M -275.63M -262.39M -250.04M -239.13M -231.31M -223.62M -216.47M -210.07M -204.56M -196.3M -188.25M -180.92M -172.4M -165.14M -155.35M
Comprehensive Income
24K 73K 61K 139K -84K -67K -29K -217K -248K -88K -122K -263K -135K n/a n/a n/a n/a n/a
Shareholders Equity
198.49M 99.46M 99.64M 58.97M 66.17M 72.33M 82.55M 89.61M 95.07M 101.73M 107.46M 109.9M 60.52M 10.46M 17.07M 11.38M 17.74M 23.68M
Total Investments
86.83M 83.88M 73.53M 49.44M 56.53M 59.01M 50.57M 62.9M 80.4M 99.61M 107.92M 59.03M 54.16M n/a n/a n/a n/a n/a